Annelise Frederick is a Chicago, Illinois based nurse practitioner. Active license number of Annelise Frederick is 209030220 for Pediatrics, Critical Care in Illinois. Her current practice location is 225 E Chicago Ave, Chicago. Patients can reach her at 312-227-4000 and her NPI number (Unique professional ID assigned by NPPES) is 1750138657. Annelise Frederick has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Annelise Frederick speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1750138657
NPI Enumeration Date:
30 Apr, 2024
NPI Last Update On:
12 Sep, 2024
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Annelise Frederick are as mentioned below.
License Number
Specialization
State
Status
209030220
Pediatrics, Critical Care
Illinois
Primary
041497621
Registered Nurse
Illinois
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Annelise Frederick 225 E Chicago Ave, Chicago, Illinois
Zip:
60611-2991
Patients can reach Annelise Frederick at 225 E Chicago Ave, Chicago, Illinois or can call to book an appointment on 312-227-4000.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.